{"contract_version":"web-product-v1","provenance":{"source_url":"https://www.frontiersin.org/articles/10.3389/fphar.2026.1996867","content_hash":"fdcd1e15f50af417cf3e282597397f0bad16d579db612c27f27b6d488c5b2a4b","story_version":1,"source_revision":null,"source_revision_status":"NOT_RECORDED_IN_PUBLIC_STORY_SCHEMA","publication_updated_at":"2026-11-11T07:51:48Z","published_at":"2026-11-11T00:00:00+00:00","hash_scope":"RECORDED_ARCHIVE_HASH_NOT_VERIFIED_ORIGINAL_BYTES"},"corrections":{"status":"PENDING_EVIDENCE","versions":[],"reason":"PUBLIC_CORRECTION_PUBLICATION_CONTRACT_REQUIRED"},"living_event":{"status":"PENDING_EVIDENCE","sources":[],"claims":[],"evidence":[],"counterevidence":[],"timeline":[],"uncertainty":[],"relations":[],"reason":"AUTHORIZED_PUBLIC_CHILD_PUBLICATION_CONTRACT_REQUIRED"},"analysis":{"contract_version":"web-product-v1","status":"PENDING_EVIDENCE","sections":[],"required_section_count":12,"section_slots":[{"section_id":1,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":2,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":3,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":4,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":5,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":6,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":7,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":8,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":9,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":10,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":11,"status":"MISSING_APPROVED_REPORT_DATA"},{"section_id":12,"status":"MISSING_APPROVED_REPORT_DATA"}],"source_story":{"story_id":193394,"version":1,"content_hash":"fdcd1e15f50af417cf3e282597397f0bad16d579db612c27f27b6d488c5b2a4b"},"approved_heading_mapping":"PENDING_EVIDENCE","depth":null,"reason":"APPROVED_ANALYSIS_PUBLICATION_AND_HEADING_CONTRACT_REQUIRED"},"story":{"story_id":193394,"title":"Renoprotective effects of salvianolic acid B in experimental diabetic kidney disease: a systematic review and meta-analysis of efficacy, mechanisms, and translational robustness","summary":"Ethnopharmacological RelevanceSalvia miltiorrhiza Bunge has a long history of use in traditional Chinese medicine, and salvianolic acid B (SalB) is one of its major water-soluble phenolic constituents. SalB and chemically defined related forms have shown potential renoprotective effects in experimental diabetic kidney disease (DKD), but the consistency and robustness of these effects across models, chemical forms, and outcomes remain unclear.Aim of the StudyTo systematically evaluate the renopro","category":"fitoterapi","country":"","published_at":"2026-11-11T00:00:00+00:00","source_url":"https://www.frontiersin.org/articles/10.3389/fphar.2026.1996867","language":"en","status":"PUBLISHED","version":1,"content_hash":"fdcd1e15f50af417cf3e282597397f0bad16d579db612c27f27b6d488c5b2a4b","subcategory":"","image_url":null,"publication_updated_at":"2026-11-11T07:51:48Z","degree":"D3","source_language_status":"KNOWN","masa_classification_status":"RECORDED","spam_assessment_status":"RECORDED","source_language":"en"},"entities":[],"related":[],"timeline":[],"evidence_visibility":"PENDING_PUBLICATION_CONTRACT","living_event_status":"PENDING_AUTHORIZED_API_CONTRACT"}